Helen T. Chifotides

4.8k total citations · 2 hit papers
58 papers, 4.2k citations indexed

About

Helen T. Chifotides is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Helen T. Chifotides has authored 58 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 23 papers in Oncology and 20 papers in Genetics. Recurrent topics in Helen T. Chifotides's work include Metal complexes synthesis and properties (22 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (19 papers) and DNA and Nucleic Acid Chemistry (13 papers). Helen T. Chifotides is often cited by papers focused on Metal complexes synthesis and properties (22 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (19 papers) and DNA and Nucleic Acid Chemistry (13 papers). Helen T. Chifotides collaborates with scholars based in United States, Italy and Ukraine. Helen T. Chifotides's co-authors include Kim R. Dunbar, B.L. Schottel, John Bacsa, A. Chouai, Lisa M. Pérez, Srđan Verstovšek, Ian D. Giles, Prithviraj Bose, Michael Shatruk and David H. Russell and has published in prestigious journals such as Journal of the American Chemical Society, Chemical Society Reviews and Angewandte Chemie International Edition.

In The Last Decade

Helen T. Chifotides

57 papers receiving 4.1k citations

Hit Papers

Anion-π interactions 2007 2026 2013 2019 2007 2013 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Helen T. Chifotides United States 27 1.6k 1.4k 1.3k 1.1k 1.1k 58 4.2k
Silvano Geremia Italy 42 2.9k 1.8× 1.9k 1.4× 2.5k 1.9× 1.1k 1.0× 1.0k 1.0× 224 6.8k
Κ. Hegetschweiler Germany 33 1.1k 0.7× 1.4k 1.0× 1.1k 0.9× 312 0.3× 976 0.9× 149 3.2k
Daishi Fujita Japan 30 2.0k 1.2× 1.2k 0.9× 990 0.8× 623 0.6× 226 0.2× 58 3.8k
Timothy C. Johnstone United States 31 2.9k 1.8× 915 0.7× 1.2k 0.9× 353 0.3× 2.6k 2.4× 80 5.9k
John C. Dewan United States 34 2.3k 1.4× 1.4k 1.0× 877 0.7× 243 0.2× 795 0.7× 134 4.4k
Yao‐Rong Zheng United States 31 3.6k 2.2× 3.1k 2.3× 2.4k 1.8× 1.3k 1.1× 1.0k 0.9× 58 6.9k
Bogdan Olenyuk United States 30 4.9k 3.0× 3.4k 2.5× 2.4k 1.8× 1.6k 1.4× 1.1k 1.0× 52 8.4k
Völker Gramlich Switzerland 50 4.4k 2.8× 2.5k 1.9× 2.6k 2.0× 901 0.8× 1.1k 1.0× 216 8.0k
Vincent M. Miskowski United States 36 2.3k 1.4× 1.2k 0.9× 2.1k 1.6× 536 0.5× 1.8k 1.7× 100 5.2k
Norman J. Rose United States 26 710 0.4× 785 0.6× 1.2k 0.9× 368 0.3× 899 0.8× 55 2.7k

Countries citing papers authored by Helen T. Chifotides

Since Specialization
Citations

This map shows the geographic impact of Helen T. Chifotides's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen T. Chifotides with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen T. Chifotides more than expected).

Fields of papers citing papers by Helen T. Chifotides

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen T. Chifotides. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen T. Chifotides. The network helps show where Helen T. Chifotides may publish in the future.

Co-authorship network of co-authors of Helen T. Chifotides

This figure shows the co-authorship network connecting the top 25 collaborators of Helen T. Chifotides. A scholar is included among the top collaborators of Helen T. Chifotides based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen T. Chifotides. Helen T. Chifotides is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chifotides, Helen T., Andrea Duminuco, Elena Torre, et al.. (2025). Emerging Therapeutic Approaches for Anemia in Myelofibrosis. Current Hematologic Malignancy Reports. 20(1). 7–7. 1 indexed citations
2.
Masárová, Lucia & Helen T. Chifotides. (2024). How I individualize selection of JAK inhibitors for patients with myelofibrosis. Blood. 145(16). 1724–1737. 2 indexed citations
3.
Kantarjian, Hagop M., Helen T. Chifotides, Fadi Haddad, et al.. (2024). Ponatinib‐review of historical development, current status, and future research. American Journal of Hematology. 99(8). 1576–1585. 9 indexed citations
4.
Masárová, Lucia, Prithviraj Bose, Naveen Pemmaraju, et al.. (2023). The role of therapy in the outcome of patients with myelofibrosis. Cancer. 129(18). 2828–2835. 3 indexed citations
5.
Chifotides, Helen T., Srđan Verstovšek, & Prithviraj Bose. (2023). Association of Myelofibrosis Phenotypes with Clinical Manifestations, Molecular Profiles, and Treatments. Cancers. 15(13). 3331–3331. 13 indexed citations
6.
Chifotides, Helen T., Lucia Masárová, & Srđan Verstovšek. (2023). SOHO State of the Art Updates and Next Questions: Novel Therapeutic Strategies in Development for Myelofibrosis. Clinical Lymphoma Myeloma & Leukemia. 23(4). 219–231. 5 indexed citations
7.
Masárová, Lucia, Prithviraj Bose, Naveen Pemmaraju, et al.. (2022). Improved survival of patients with myelofibrosis in the last decade: Single‐center experience. Cancer. 128(8). 1658–1665. 26 indexed citations
8.
Mascarenhas, John, Hélène F.E. Gleitz, Helen T. Chifotides, et al.. (2022). Biological drivers of clinical phenotype in myelofibrosis. Leukemia. 37(2). 255–264. 28 indexed citations
9.
Chifotides, Helen T. & Srđan Verstovšek. (2022). EXABS-164-MPN Novel Therapeutics in Development for Myelofibrosis. Clinical Lymphoma Myeloma & Leukemia. 22. S72–S74. 1 indexed citations
10.
Chifotides, Helen T., Prithviraj Bose, & Srđan Verstovšek. (2022). Momelotinib: an emerging treatment for myelofibrosis patients with anemia. Journal of Hematology & Oncology. 15(1). 7–7. 58 indexed citations
11.
Masárová, Lucia, Courtney D. DiNardo, Prithviraj Bose, et al.. (2021). Single-center experience with venetoclax combinations in patients with newly diagnosed and relapsed AML evolving from MPNs. Blood Advances. 5(8). 2156–2164. 30 indexed citations
12.
Chifotides, Helen T., et al.. (2021). Accelerated Phase of Myeloproliferative Neoplasms. Acta Haematologica. 144(5). 484–499. 28 indexed citations
13.
Chifotides, Helen T., Lucia Masárová, Mansour Alfayez, et al.. (2020). Outcome of patients with IDH1/2-mutated post–myeloproliferative neoplasm AML in the era of IDH inhibitors. Blood Advances. 4(21). 5336–5342. 37 indexed citations
14.
15.
Deubel, Dirk V. & Helen T. Chifotides. (2007). Guanine binding to dirhodium tetracarboxylate anticancer complexes: quantum chemical calculations unravel an elusive mechanism. Chemical Communications. 3438–3438. 23 indexed citations
16.
Chifotides, Helen T. & Kim R. Dunbar. (2006). Head‐to‐Head Cross‐Linked Adduct between the Antitumor Unit Bis(μ‐N,N′‐di‐p‐tolylformamidinato)dirhodium(II,II) and the DNA Fragment d(GpG). Chemistry - A European Journal. 12(25). 6458–6468. 19 indexed citations
17.
Chifotides, Helen T. & Kim R. Dunbar. (2005). Interactions of Metal—Metal‐Bonded Antitumor Active Complexes with DNA Fragments and DNA. ChemInform. 36(24). 2 indexed citations
18.
Chifotides, Helen T. & Kim R. Dunbar. (2005). Interactions of Metal−Metal-Bonded Antitumor Active Complexes with DNA Fragments and DNA. Accounts of Chemical Research. 38(2). 146–156. 409 indexed citations
19.
Campos-Fernandez, C.S., B.L. Schottel, Helen T. Chifotides, et al.. (2005). Anion Template Effect on the Self-Assembly and Interconversion of Metallacyclophanes. Journal of the American Chemical Society. 127(37). 12909–12923. 317 indexed citations
20.
Chifotides, Helen T., et al.. (1994). Synthesis, spectroscopic and magnetic resonance studies of mercury(II) and methylmercury(II) complexes of azathioprine, a biologically active mercaptopurine derivative. Journal of Inorganic Biochemistry. 55(3). 203–216. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026